VANGUARD GROUP INC 13D and 13G filings for Lifecore Biomedical, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:22 am Sale |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
VANGUARD GROUP INC | 1,257,836 4.270% |
-414,005 (-24.76%) |
Filing |
| 2021-02-10 11:14 am Purchase |
2020-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
VANGUARD GROUP INC | 1,671,841 5.720% |
52,739 (+3.26%) |
Filing |